Previous webinar

14 March, 2024





Kicking off the 2024 webinar series, our invited speakers will talk through complement diseases and C3G particularly.

Watch our recorded session


Dr. Bjoern Cochlovius

CEO Eleva

Eleva insight
Eleva’s origins and experience, who we are today, and our ambitions for the future.

Prof. Dr. Peter Zipfel

Head of department infection biology; Leibniz-Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute Jena

Factor H and complement in a nutshell
The role of Factor H in the complement system and in complement-mediated diseases

Prof. Dr. Dinesh Khullar

Chairman Nephrology & Renal Transplant Medicine at Max Superspeciality Hospital Saket New Delhi

C3 Glomerulopathy in India
Prevalence, immunological and genetic differences of C3 Glomerulopathy in India.

What is

Our webinar series offers firsthand insights from experts, scientists and clinicians about C3 Glomerulopathy (C3G) such as epidemiology, diagnosis, treatment, management and coping strategies. You will hear about all the relevant aspects, including eleva’s initiatives to develop new treatment options for this ultrarare disease with high unmet medical need.
Join the series for regular updates on Eleva’s clinical development efforts.

Stay in the loop

Next webinars


Edition FOUR of our webinar series will zoom in on spectrum 2 and provide more insight into Eleva's technology.

Did you miss this video?

Watch the video